Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/BAJAJHCARE stock hub

NSE/BAJAJHCARE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/BAJAJHCAREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.6B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/BAJAJHCARE

In the news

Latest news · NSE/BAJAJHCARE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E21.4

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/BAJAJHCARE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

INR

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	918
Employees Change	-131%
Employees Change Percent	-12.49
Enterprise value	INR 12.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE411U01027
Last refreshed	2026-05-10
Market cap	INR 10.6B
Price	INR 338
Price currency	INR
Rev Per Employee	6,671,529.41x
Sector	Healthcare
Sic	2833
Symbol	nse/BAJAJHCARE
Website	https://www.bajajhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.68%
EV Earnings	25.61x
EV/EBIT	19.21x
EV/EBITDA	14.1x
EV/Sales	2.08x
P/B ratio	2.19x
P/E ratio	21.37x
P/S ratio	1.74x
PE Ratio10 Y	19.62x
PE Ratio5 Y	21.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.84%
EBITDA Margin	14.73%
Gross margin	44.95%
Gross Profit	INR 2.8B
Gross Profit Growth	13.19%
Gross Profit Growth Q	42.72%
Gross Profit Growth3 Y	15.35%
Gross Profit Growth5 Y	9.05%
Net Income	INR 497.9M
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Net Income Growth3 Y	-4.35%
Net Income Growth5 Y	-7.02%
Pretax Margin	10.03%
Profit Margin	8.13%
Profit Per Employee	INR 542,424
Profitable Years	1
Roa5y	8.66
Roe5y	17.55
ROIC	7.96
Roic5y	13.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.67%
Cagr3y	2.89%
Div CAGR3	-12.64%
EPS Growth Quarters	7
EPS Growth Years	1
EPS Growth3 Y	-9.3
EPS Growth5 Y	-9.95
Revenue Growth	17.32x
Revenue Growth Q	1x
Revenue Growth Quarters	7x
Revenue Growth Years	1x
Revenue Growth3 Y	-3.92x
Revenue Growth5 Y	-1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 140.1M
Current Assets	INR 6.4B
Current Liabilities	INR 3.3B
Debt	INR 2.4B
Debt EBITDA	INR 2.63
Debt Equity	INR 0.49
Equity	INR 4.9B
Interest Coverage	3.33
Net Cash	INR -2.2B
Net Cash By Market Cap	INR -21.05
Net Debt EBITDA	INR 2.48
Net Debt Equity	INR 0.46
Tangible Book Value	INR 4.8B
Tangible Book Value Per Share	INR 153
WACC	6.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working Capital Turnover	INR 2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.68%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1
Dividend Years	6
Dividend Yield	0.3%
Ex Div Date	2025-09-19
Last Dividend	INR 1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.65%
200-day SMA	404.9
3Y total return	8.92%
50-day SMA	322
50-day SMA vs 200-day SMA	50under200
All Time High	745
All Time High Change	-54.57%
All Time High Date	2025-03-19
All Time Low	257.5
All Time Low Change	31.46%
All Time Low Date	2022-06-20
ATR	13.5
Beta	0.29
Ch YTD	-18.47
High	340.5
High52	608.9
High52 Date	2025-05-26
High52ch	-44.42%
Low	327
Low52	273.3
Low52 Date	2026-03-16
Low52ch	23.86%
Ma50ch	5.12%
Price vs 200-day SMA	-16.41%
RSI	54.67
RSI Monthly	42.93
RSI Weekly	42.63
Sharpe ratio	-1x
Sortino ratio	-1.43
Total Return	-12.39%
Tr YTD	-18.47
Tr1m	7.62%
Tr1w	3.23%
Tr3m	-9.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 664M
Operating Income Growth	12.14
Operating Income Growth Q	331.4
Operating Income Growth3 Y	-10.39
Operating Income Growth5 Y	-9.08
Operating margin	10.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,537,993%
Shares Insiders	63.75%
Shares Institutions	5.11%
Shares Qo Q	-0.7%
Shares Yo Y	12.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	166,507.2x
Bv Per Share	154.6
Ch1m	7.62
Ch1w	3.23
Ch1y	-35.8
Ch3m	-9.38
Ch3y	8.13
Ch6m	-23.57
Change	-0.37%
Change From Open	-0.44
Close	339.7
Days Gap	0.07
Depreciation Amortization	238,286,000
Dollar Volume	141,068,667.6
Earnings Date	2026-05-08
EBIT	INR 664M
EBITDA	INR 902.2M
EPS	INR 15.38
F Score	1
Fiscal Year End	March
Founded	1,993
Graham Number	234.80776
Graham Upside	-30.62
Income Tax	INR 91.4M
Is Primary Listing	0
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Lynch Fair Value	INR 79.19
Lynch Upside	-76.6
Ma150	386.3
Ma150ch	-12.38%
Ma20	333.6
Ma20ch	1.47%
Next Earnings Date	2026-05-29
Open	340
Payment Date	2025-10-26
Position In Range	84.87
Ppne	2,551,662,000
Price Date	2026-05-08
Price EBITDA	INR 11.79
Ptbv Ratio	2.21
Relative Volume	2.52x
Revenue	6,124,464,000x
Tax By Revenue	1.49x
Tax Rate	14.87%
Tr6m	-23.57%
Volume	416,808

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/BAJAJHCARE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$1.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-12.4%

Next ex-dividend date: 2025-09-19

Performance

NSE/BAJAJHCARE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/BAJAJHCARE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.1%

Share of float held by funds and institutions

Insider ownership

+63.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.7%

Negative means the company is buying back shares.

Technical

NSE/BAJAJHCARE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.7

Neutral momentum band

Price vs 200-day MA

-16.4%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

-1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/BAJAJHCARE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BAJAJHCARE stock rating?

nse/BAJAJHCARE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BAJAJHCARE analysis?

The full report lives at /stocks/nse/BAJAJHCARE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BAJAJHCARE?

The latest report frames nse/BAJAJHCARE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BAJAJHCARE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.